Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-staphylococcal Phages in Diabetic Foot Ulcers
NCT04289948Phase 2Withdrawn
- Sponsor
- University Hospitals of Derby and Burton
- Start
- Mar 2019
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot infection (DFI) and diabetic foot ulcer (DFU) (5 arms), sponsored by University Hospitals of Derby and Burton. Primary endpoint: Safety of the use of anti-staphylococcal phages therapy on the wound bacterial microbiome at 7 months. Planned start Mar 2019; status: withdrawn.
02
Conditions
diabetic foot infection (DFI)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04289948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289948.